Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions for the treatment of ARDS or IRDS containing 3-(cycloproplymethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant

Compositions for the treatment of ARDS or IRDS containing 3-(cycloproplymethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant

US Patent 6436970 · Granted Aug 20, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Device for dosing and dry nebulization2017
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvi2016
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvi2013
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvi2011
Compositions comprising phenylaminothiophenacetic acid derivatives for the treat2007
Combination of C1-INH and lung surfactant for the treatment of respiratory disor2006
Compositions2006
Compositions2006
Compositions comprising phenylaminothiophenacetic acid derivatives for the treat2005
Process for the production of powdered pulmonary surfactant preparations2001
Compositions for treating IRDS and ARDS with a combination of a Glucocorticoster1999
Use of oxirancarboxylic acids for the treatment of hyperlipemia1990